The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B
Abstract
Inherited diseases might be treated by introducing normal genes into a patient's somatic tissues to correct the genetic defects. In the case of hemophilia resulting from a missing clotting factor, the required gene could be introduced into any cell as long as active factor reached the circulation. We previously showed that retroviral vectors can efficiently transfer genes into normal skin fibroblasts and that the infected cells can produce high levels of a therapeutic product in vitro. In the current study, we examined the ability of skin fibroblasts to secrete active clotting factor after infection with different retroviral vectors encoding human clotting factor IX. Normal human fibroblasts infected with one vector secreted greater than 3 micrograms factor IX/10(6) cells/24 h. Of this protein, greater than 70% was structurally and functionally indistinguishable from human factor IX derived from normal plasma. This suggests that infected autologous fibroblasts might provide therapeutic levels of factor IX if transplanted into patients suffering from hemophilia B. By transplanting normal diploid fibroblasts infected with the factor IX vectors, we showed that human factor IX can be produced and is circulated at readily detectable levels in rats and mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo sequence requirements of the SV40 early promoter region
Benoist, C., & Chambon, P. (1981) · Nature · doi:10.1038/290304a0 · Cited by 1,074
Cited by
Vascular niche for adult hippocampal neurogenesis
Palmer, T. D., Willhoite, A. R., & Gage, F. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001002)425:4<479::aid-cne2>3.0.co;2-3 · Cited by 1,838
Self-citationHuman gene therapy comes of age
Miller, A. D. (1992) · Nature · doi:10.1038/357455a0 · Cited by 908
Self-citationNeural stem cells from adult hippocampus develop essential properties of functional CNS neurons
Song, H.-J., Stevens, C. F., & Gage, F. H. (2002) · Nature Neuroscience · doi:10.1038/nn844 · Cited by 642
Kavanaugh, M. P., Miller, D. G., Zhang, W., Law, W., Kozak, S. L., Kabat, D., & Miller, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7071 · Cited by 586
Self-citationPalmer, T. D., Rosman, G. J., Osborne, W. R., & Miller, A. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1330 · Cited by 479
Self-citation
Metadata
- Authors
- Palmer, T., Thompson, A., & Miller, A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1989-02-01
- Volume
- 73
- Issue
- 2
- Pages
- 438-445
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1514924602
- Cited by
- 175
- References
- 1
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. https://app.cochat.ai/papers/10.1182/blood.v73.2.438.438
- The paper
- Palmer, T., Thompson, A., & Miller, A. (1989). Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood. https://doi.org/10.1182/blood.v73.2.438.438
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.